InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,780.05
(
-0.21%
)
US TECH 100
19,707.60
(
-0.09%
)
Dow Jones
42,454.12
(
-0.14%
)
Brent Oil
79.06
(
3.17%
)
Bitcoin
60,112.49
(
-0.77%
)

Replies to post #224234 on Biotech Values

Replies to #224234 on Biotech Values
icon url

DewDiligence

03/21/19 5:21 PM

#224236 RE: rfj1862 #224234

Most of ENTA's current EV derives from the Mavyret royalty stream, which is running at $200M per year (pre-tax). I.e. investors are not paying so much for the NASH/PBC, RSV, and HBV programs.